SearchClinical development for holistic CVRM therapies
Expertise to bring your cutting-edge treatments to patients faster
Cardiovascular, Renal and Metabolic (CVRM) health represents the fastest expanding disease spectrum globally, linking cardiovascular diseases with related comorbidities, such as obesity, diabetes and chronic kidney disease. Due to shared risk factors, a better understanding of patient populations and interconnections of these conditions is needed for the best outcomes.
IQVIA Biotech’s CVRM team understands the unique considerations of planning and executing clinical trials across these three areas. Our combined strength in CVRM expertise, biotech focus and integrated real world data forms a partnership aimed at accelerating the delivery of treatments to patients.
CVRM expertise
With more than 500 CVRM studies in the last 5 years, IQVIA Biotech has been instrumental in assisting biotech companies to meet critical study milestones, expand clinical development worldwide, and maximize patient impact.
For more than 25 years, we have been prioritizing your best interests by providing:
- Medical expertise across all cardiovascular, renal and metabolic therapeutic areas
- Support in clinical trial design, delivery and logistics
- Optimized communication for efficient achievement of trial milestones
Operational knowledge
Our CVRM team has operational experience and expertise across a broad spectrum of chronic and acute indications. From acute coronary syndrome, heart failure, kidney disease and diabetes, to hyperlipidemia, and more, we have strong existing investigator relationships and institutional knowledge of operational best practices.
OUR LATEST THINKING
Dedicated CVRM team
Our dedicated CVRM project management team integrates the IQVIA Biotech clinical program strategy and delivery with IQVIA Centers of Excellence for cardiovascular, nephrology and endocrinology.
Drive smarter decisions for your clinical trial
- Reduce patient burden with Decentralized and Hybrid trial solutions
- Model and predict event rates with the world’s largest healthcare data source
- Optimize study protocols by refining eligibility criteria and schedule of assessments
- Create Direct-to-patient multi-channel recruitment campaigns for rare and common disease populations
- Enable patient-centered recruitment and tailored site strategies through new technology solutions
- Monitor safety and efficacy endpoints in near real time with wearables and connected devices
Generate and disseminate the right real world evidence (RWE) to meet stakeholder needs with confidence.
Build on our experience of more than 300 rare disease studies to fulfill your promise of hope to millions around the world.
Connect data, analytics, domain expertise, and technology to uncover actionable insights and maximize commercial effectiveness.